Outcome after Systemic Thrombolysis Is Predicted by Age and Stroke Severity: An Open Label Experience with Recombinant Tissue Plasminogen Activator and Tirofiban
Abstract
Share and Cite
Seitz, R.J.; Sukiennik, J.; Siebler, M. Outcome after Systemic Thrombolysis Is Predicted by Age and Stroke Severity: An Open Label Experience with Recombinant Tissue Plasminogen Activator and Tirofiban. Neurol. Int. 2012, 4, e9. https://doi.org/10.4081/ni.2012.e9
Seitz RJ, Sukiennik J, Siebler M. Outcome after Systemic Thrombolysis Is Predicted by Age and Stroke Severity: An Open Label Experience with Recombinant Tissue Plasminogen Activator and Tirofiban. Neurology International. 2012; 4(2):e9. https://doi.org/10.4081/ni.2012.e9
Chicago/Turabian StyleSeitz, Rudiger J., Judith Sukiennik, and Mario Siebler. 2012. "Outcome after Systemic Thrombolysis Is Predicted by Age and Stroke Severity: An Open Label Experience with Recombinant Tissue Plasminogen Activator and Tirofiban" Neurology International 4, no. 2: e9. https://doi.org/10.4081/ni.2012.e9